Without clear protocols to catch errors, artificial intelligence’s growing role in science could do more harm than good.

It was just before the COVID-19 pandemic began that Hiroaki Kitano, CEO of Sony AI Inc., found himself in a bunker. In his last trip before the world went into lockdown, Kitano visited the ...

As COVID-19 cases continue to rise, physicians have begun to repurpose existing drugs in an attempt to find something that will help patients get better. In a pilot study at the end of March, 12 ...

The use of artificial intelligence (AI) in drug development has been hyped up for some time now – and the COVID-19 pandemic is finally a chance for these technologies to prove their worth.

This approach was also favored in the initial fight against COVID-19. However ... the Department of Organic Chemistry at the Faculty of Science of UNIGE, is opening a new paradigm for the design ...